旅游者疟疾化疗预防中的争议和误解
Lin H Chen1, Mary E Wilson, Patricia Schlagenhauf
1Travel Medicine Center, Division of Infectious Diseases, Mount Auburn Hospital, Cambridge, MA 02238, USA. lchen@hms.harvard.edu
JAMA
|May 24, 2007
概括
疟疾化疗预防指导方针各不相同,而梅弗洛昆的安全性与其他药物相比相当. 普拉马奎因是有效的对抗Plasmodium vivax复发,但目前的指南缺乏共识.
科学领域:
- 热带医学和传染病
- 全球卫生与流行病学
- 药理学和药物安全问题
背景情况:
- 疟疾预防的争议源于数据缺口,相互矛盾的证据和不同的风险值.
- 关于疟疾严重程度,药物耐受性和驱逐剂有效性的误解,推动了预防辩论.
研究的目的:
- 为了比较国际疟疾化学预防指南,并确定建议中的差异.
- 审查梅弗洛的耐受性,重点关注神经精神效应和性能影响.
- 检查目前预防Plasmodium vivax疟疾复发的治疗方案的失败,并探索替代方案.
主要方法:
- 在2006年12月之前对MEDLINE/PubMed的系统文献搜索.
- 关键词包括疟疾,化疗预防,旅游,美弗洛,神经精神病学不良事件,耐受性,活性疟疾和普里马.
- 从选定的文章引用也被审查,没有语言限制.
主要成果:
- 目前的疟疾化学预防指导方针之间存在重大差距和冲突,涉及药物选择和预防持续时间.
- 有控制的研究表明,梅弗洛昆的严重神经精神病学不良事件发生率与其他药物相比,并且不会损害性能.
- 目前的一线化疗预防不能预防Plasmodium vivax复发,而普里马奎因在预防这些复发方面表现出有效性.
结论:
- 旅行者有效预防疟疾需要了解流行病学和宿主-寄生虫相互作用.
- 缺乏标准化的建议和持续的争议使疟疾预防策略复杂化.
- 国际共识对于协调指导方针,解决争议和改善遵守预防措施至关重要.
相关概念视频
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...


